Low-dose aspirin linked to 15% lower risk of type 2 diabetes in older adults

New research to be presented at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2-6 October) shows that use of low dose (100mg daily) aspirin among older adults aged 65 years and older is associated with a 15% lower risk of developing type 2 diabetes.

Eko Health Launches AI-Enhanced Digital Stethoscope

What You Should Know: Eko Health today announced the launch of its next-generation AI-enhanced digital stethoscope, CORE 500™. Engineered to enhance diagnostic accuracy and early

June 27, 2023

Boston Scientific blood-blocking agent tied to additional 2 deaths, 8 injuries

Dive Brief: The Food and Drug Administration updated the recall notice for a Boston Scientific product that blocks blood flow. Boston Scientific recalled the product,

October 21, 2024

From potential to practice: A blueprint for responsible AI in healthcare

Researchers developed comprehensive AI guidelines to ensure safe, equitable, and effective integration into healthcare, with a case study highlighting ambient documentation applications.

December 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.